The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - GenomeDx
Patents, Royalties, Other Intellectual Property - GenomeDx
Travel, Accommodations, Expenses - GenomeDx

Characterization of PSMA and 18F-fluciclovine transporter gene expression in localized prostate cancer.
 
Carissa Chu
No Relationships to Disclose
 
Mohammed Alshalalfa
Employment - Decipher Biosciences
 
Martin Sjöström
Research Funding - PFS Genomics (Inst); PFS Genomics (Inst)
 
Shuang Zhao
Employment - PFS Genomics (I)
Leadership - PFS Genomics (I)
Patents, Royalties, Other Intellectual Property - Patent applications jointly between the University of Michigan OTT and GenomeDx Biosciences. Patent applications jointly between the University of Michigan OTT and Celgene. (Inst)
Other Relationship - GenomeDx
 
Annika Herlemann
No Relationships to Disclose
 
Jonathan Chou
Stock and Other Ownership Interests - Array BioPharma (I); Atara Biotherapeutics (I); Celgene (I)
 
Brandon Arvin Virgil Mahal
No Relationships to Disclose
 
Amar Upadhyaya Kishan
Honoraria - Varian Medical Systems; ViewRay; ViewRay
Consulting or Advisory Role - Janssen
 
Daniel Eidelberg Spratt
Consulting or Advisory Role - Blue Earth Diagnostics; Janssen Oncology
 
Jeffrey Karnes
No Relationships to Disclose
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen
Consulting or Advisory Role - Beigene; Fortis; Janssen Oncology; Tolero Pharmaceuticals
Research Funding - Janssen (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Janssen
 
Anthony C. Wong
No Relationships to Disclose
 
Sima P. Porten
Honoraria - photocure
Consulting or Advisory Role - Bristol-Myers Squibb; Photocure
Research Funding - Photocure (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Thomas Hope
Honoraria - GE Healthcare
Consulting or Advisory Role - Curium Pharma; Ipsen
Research Funding - Advanced Accelerator Applications (Inst); GE Healthcare; Philips Healthcare
Travel, Accommodations, Expenses - GE Healthcare
 
Elai Davicioni
Employment - Decipher Biosciences
Stock and Other Ownership Interests - Decipher Biosciences
 
Paul L. Nguyen
Stock and Other Ownership Interests - Augmenix; Volatilyx (I)
Consulting or Advisory Role - Astellas Pharma; Augmenix; Augmenix; Bayer; Biogen (I); Blue Earth Diagnostics; Boston Scientific; Coda; Dendreon; Ferring; GenomeDx; GigaGen (I); Janssen Oncology; Medivation; Nanobiotix
Research Funding - Astellas Pharma; Janssen; Nanobiotix; Wako Diagnostics (I)
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
Travel, Accommodations, Expenses - Ferring
 
Peter Carroll
Honoraria - Intuitive Surgical
Consulting or Advisory Role - Nutcracker Therapeutics, Inc.
 
Edward M. Schaeffer
Consulting or Advisory Role - Abbvie; OPKO Diagnostics
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; PFS Genomics; SerImmune
Honoraria - Genentech
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Celgene; EMD Serono; Genzyme; Janssen Biotech; Medivation/Astellas
Research Funding - Zenith Epigenetics
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Matthew R. Cooperberg
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Dendreon; Steba Biotech